Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

What AstraZeneca could cost London stock market if it moves to US

IN FULL

The Independent UK · Jul 2, 2025

Fears over £160bn blow to London’s stock market as AstraZeneca considers listing move to US

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate

The Independent UK · Jul 2, 2025

Business news live: Gilt yields spike on Reeves exit speculation and CEO of AstraZeneca discusses leaving London

Stock markets updates and business news from Wednesday

The Independent UK · Jul 2, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca boss ‘wants to shift stock market listing to US’

Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company and considered shifting its domicile

The Guardian - UK · Jul 1, 2025

IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIA

IonQ just hit investors with two pieces of big news. One shows proof of the company's tech being useful near-term. The other looks to aid its long-term goals.

MarketBeat · Jun 12, 2025

‘Transformational’ new breast cancer drug could halt the growth of tumours

A trial funded by AstraZeneca found the drug is effective in stopping cancer cells from using hormones to grow

The Independent UK · Jun 2, 2025

Short Sellers Are Taking Aim at Buy-Rated Tempus AI. Should You Buy TEM Stock Here?

Tempus AI stock fell over 19% after Spruce Point Capital released a short report. Can TEM stock recover?

Barchart · May 29, 2025

Read news from The Economist, FT, and more,
with one subscription

How the love story between von der Leyen and Pfizer turned sour

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story between Ursula von der Leyen and big pharma Pfizer.

Euronews · May 14, 2025

Drug price cuts: what is Trump planning and what will it mean for big pharma?

President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included

The Guardian - UK · May 13, 2025

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

MarketBeat · May 8, 2025

AstraZeneca Moves Some Production To US Amid Tariff Threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.

International Business Times · Apr 29, 2025

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

The Guardian - UK · Apr 29, 2025

AstraZeneca plots US expansion despite Trump tariff threat

The drug maker said it is ‘firmly committed to investing and growing in the US’ amid potential import tariffs on the pharmaceutical industry.

Evening Standard · Apr 29, 2025

Trade war with China to hit US healthcare

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Al Jazeera · Apr 23, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard · Apr 23, 2025

Drug firm bosses call for price increases in Europe amid tariff uncertainty

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

MarketBeat · Apr 22, 2025

Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal

Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.

The Independent UK · Apr 17, 2025

Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?

TRUMP TARIFFS: UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports

The Guardian - UK · Apr 17, 2025

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Apr 16, 2025

Scramble underway to stop Trump tariffs hitting Britain’s pharmaceutical industry

Donald Trump has warned tariffs on pharmaceuticals would come ‘in the not-too-distant future’

Evening Standard · Apr 16, 2025

UK scrambling to get Donald Trump to slash tariffs to zero, says minister as US threatens medicines levies

Tariffs on Britain’s pharmaceutical industry could deal a severe blow, potentially costing firms billions of pounds

The Independent UK · Apr 10, 2025

‘Game-changing’ breast cancer pill to be offered on NHS

The new treatment helps to slow or stop the spread of cancer cells

The Guardian - UK · Apr 10, 2025

‘Gamechanging’ breast cancer pill to be offered on NHS in England and Wales

U-turn by medicines watchdog means about 3,000 women with advanced forms of disease could benefit each year

The Independent UK · Apr 10, 2025

‘Landmark moment’ as new pill approved for common type of advanced breast cancer

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move.

The Conversation · Apr 8, 2025

Uganda’s boda boda bikes are deadly polluters: study models how going electric could save lives

In Uganda, motorcycles known as boda bodas are a key part of the transport system. The country has over 1.5 million boda bodas on the road, amounting to roughly 70% of all vehicles. Boda bodas are crucial in providing last mile transport for people and goods on short trips because…

The Guardian - UK · Apr 6, 2025

China, America and pay inject drama into AstraZeneca’s AGM

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

1 … 8 9 10 11

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.